In the last 12 months, insiders at Terns Pharmaceuticals, Inc. ($TERN) filed 157 transactions with the SEC: 21 open-market purchases totaling $5,390,503 and 47 sales totaling $11,743,358. Net insider sentiment: net selling.
Terns Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Burroughs Amy L. (Chief Executive Officer) — 30 transactions totaling $7,277,146
- Lu Hongbo (Director) — 2 transactions totaling $4,999,995
- Vivo Opportunity, LLC (TenPercentOwner) — 9 transactions totaling $2,796,859
- Quigley Jill M. (Not found) — 21 transactions totaling $1,246,215
- GORDON CARL L (Director) — 6 transactions totaling $561,640
View all SEC Filings for Terns Pharmaceuticals, Inc. (TERN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 942 | $52.75 | 105,673.0000 | 91,701,529 | 0.88% | 0.00% |
| March 16, 2026 | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 11813 | $46.57 | 300,065.0000 | 91,701,529 | 3.79% | 0.01% |
| March 16, 2026 | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 2770 | $47.30 | 297,295.0000 | 91,701,529 | 0.92% | 0.00% |
| March 16, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 14583 | $0.00 | 955,534.0000 | 91,701,529 | 1.50% | 0.02% |
| March 16, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 14583 | $4.64 | 311,878.0000 | 91,701,529 | 4.91% | 0.02% |
| Feb. 17, 2026 | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 2341 | $38.07 | 309,537.0000 | 91,701,529 | 0.75% | 0.00% |
| Feb. 17, 2026 | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 8159 | $39.22 | 301,378.0000 | 91,701,529 | 2.64% | 0.01% |
| Feb. 17, 2026 | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 4083 | $39.80 | 297,295.0000 | 91,701,529 | 1.35% | 0.00% |
| Feb. 17, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 14583 | $0.00 | 970,117.0000 | 91,701,529 | 1.48% | 0.02% |
| Feb. 17, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 14583 | $4.64 | 311,878.0000 | 91,701,529 | 4.91% | 0.02% |
| Feb. 1, 2026 | Azelby Robert | Not found | A | Stock Option (Right to Buy) | 1697 | $0.00 | 1,697.0000 | 91,701,529 | 9999.99% | 0.00% |
| Feb. 1, 2026 | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 1697 | $0.00 | 1,697.0000 | 91,701,529 | 9999.99% | 0.00% |
| Feb. 1, 2026 | FELLOWS DAVID A | Not found | A | Stock Option (Right to Buy) | 2828 | $0.00 | 2,828.0000 | 91,701,529 | 9999.99% | 0.00% |
| Feb. 1, 2026 | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 1697 | $0.00 | 1,697.0000 | 91,701,529 | 9999.99% | 0.00% |
| Feb. 1, 2026 | Turner Heather D | Not found | A | Stock Option (Right to Buy) | 1697 | $0.00 | 1,697.0000 | 91,701,529 | 9999.99% | 0.00% |
| Feb. 1, 2026 | Quigley Jill M. | Not found | A | Stock Option (Right to Buy) | 1697 | $0.00 | 1,697.0000 | 91,701,529 | 9999.99% | 0.00% |
| Jan. 15, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 27083 | $0.00 | 999,283.0000 | 91,701,529 | 2.64% | 0.03% |
| Jan. 15, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 14583 | $0.00 | 984,700.0000 | 91,701,529 | 1.46% | 0.02% |
| Jan. 14, 2026 | Kuriakose Emil | Chief Medical Officer | A | Common Stock | 56250 | $0.00 | 106,615.0000 | 91,701,529 | 111.68% | 0.06% |
| Jan. 15, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 27083 | $4.64 | 351,461.0000 | 91,701,529 | 8.35% | 0.03% |
| Jan. 15, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 27083 | $4.64 | 324,378.0000 | 91,701,529 | 9.11% | 0.03% |
| Jan. 14, 2026 | Burroughs Amy L. | Chief Executive Officer | A | Common Stock | 150000 | $0.00 | 297,295.0000 | 91,701,529 | 101.84% | 0.16% |
| Jan. 14, 2026 | Gengos Andrew | Chief Financial Officer | A | Stock Option (Right to Buy) | 137500 | $0.00 | 137,500.0000 | 91,701,529 | 9999.99% | 0.15% |
| Jan. 14, 2026 | Gengos Andrew | Chief Financial Officer | A | Common Stock | 68750 | $0.00 | 101,788.0000 | 91,701,529 | 208.09% | 0.07% |
| Jan. 14, 2026 | Kuriakose Emil | Chief Medical Officer | A | Stock Option (Right to Buy) | 112500 | $0.00 | 112,500.0000 | 91,701,529 | 9999.99% | 0.12% |
| Jan. 15, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 14583 | $4.64 | 366,044.0000 | 91,701,529 | 4.15% | 0.02% |
| Jan. 15, 2026 | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 61228 | $37.02 | 304,816.0000 | 91,701,529 | 16.73% | 0.07% |
| Jan. 15, 2026 | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 7521 | $37.53 | 297,295.0000 | 91,701,529 | 2.47% | 0.01% |
| Jan. 14, 2026 | Burroughs Amy L. | Chief Executive Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 91,701,529 | 9999.99% | 0.33% |
| Jan. 15, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 27083 | $0.00 | 1,026,366.0000 | 91,701,529 | 2.57% | 0.03% |
| Jan. 5, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Restricted Stock Unit | 150000 | $0.00 | 0.0000 | 91,701,529 | 100.00% | 0.16% |
| Jan. 2, 2026 | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 955 | $38.36 | 50,365.0000 | 91,701,529 | 1.86% | 0.00% |
| Jan. 2, 2026 | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 200 | $39.60 | 51,320.0000 | 91,701,529 | 0.39% | 0.00% |
| Jan. 2, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 21551 | $0.00 | 1,053,449.0000 | 91,701,529 | 2.00% | 0.02% |
| Jan. 5, 2026 | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 71339 | $38.10 | 147,295.0000 | 91,701,529 | 32.63% | 0.08% |
| Jan. 5, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 150000 | $0.00 | 218,634.0000 | 91,701,529 | 218.55% | 0.16% |
| Jan. 2, 2026 | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 21551 | $4.64 | 68,634.0000 | 91,701,529 | 45.77% | 0.02% |
| Nov. 4, 2025 | Quigley Jill M. | Not found | M | Stock Option (Right to Buy) | 24520 | $0.00 | 3,955.0000 | 91,701,529 | 86.11% | 0.03% |
| Nov. 4, 2025 | Quigley Jill M. | Not found | M | Common Stock | 24520 | $9.24 | 24,520.0000 | 91,701,529 | 9999.99% | 0.03% |
| Nov. 4, 2025 | Quigley Jill M. | Not found | S | Common Stock | 24520 | $18.00 | 0.0000 | 91,701,529 | 100.00% | 0.03% |
| Oct. 1, 2025 | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 944 | $7.85 | 51,520.0000 | 91,701,529 | 1.80% | 0.00% |
| July 1, 2025 | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 853 | $4.27 | 52,464.0000 | 79,507,474 | 1.60% | 0.00% |
| June 27, 2025 | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.93 | 25,000.0000 | 79,507,474 | 25.00% | 0.01% |
| June 27, 2025 | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.93 | 20,000.0000 | 79,507,474 | 33.33% | 0.01% |
| June 25, 2025 | Burroughs Amy L. | Chief Executive Officer | P | Common Stock | 23314 | $3.87 | 47,083.0000 | 79,507,474 | 98.09% | 0.03% |
| June 13, 2025 | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.75 | 5,000.0000 | 79,507,474 | 9999.99% | 0.01% |
| June 13, 2025 | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.72 | 10,000.0000 | 79,507,474 | 100.00% | 0.01% |
| June 16, 2025 | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.95 | 15,000.0000 | 79,507,474 | 50.00% | 0.01% |
| June 11, 2025 | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 79,507,474 | 9999.99% | 0.06% |
| June 11, 2025 | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 79,507,474 | 9999.99% | 0.06% |
| June 11, 2025 | Turner Heather D | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 79,507,474 | 9999.99% | 0.06% |
| June 11, 2025 | Lu Hongbo | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 79,507,474 | 9999.99% | 0.06% |
| June 11, 2025 | FELLOWS DAVID A | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 79,507,474 | 9999.99% | 0.06% |
| June 11, 2025 | Quigley Jill M. | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 79,507,474 | 9999.99% | 0.06% |
| April 1, 2025 | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 952 | $2.49 | 53,317.0000 | 79,507,474 | 1.75% | 0.00% |
| Feb. 24, 2025 | Gengos Andrew | Chief Financial Officer | A | Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 79,507,474 | 9999.99% | 0.94% |
| Feb. 20, 2025 | Azelby Robert | Not found | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 79,507,474 | 9999.99% | 0.11% |
| Nov. 30, 2024 | Burroughs Amy L. | Chief Executive Officer | P | Common Stock | 510 | $5.11 | 19,609.0000 | 77,819,658 | 2.67% | 0.00% |
| Jan. 30, 2025 | Burroughs Amy L. | Chief Executive Officer | A | Stock Option (Right to Buy) | 1075000 | $0.00 | 1,075,000.0000 | 79,507,474 | 9999.99% | 1.35% |
| Feb. 1, 2025 | Lu Hongbo | Not found | A | Stock Option (Right to Buy) | 10657 | $0.00 | 10,657.0000 | 79,507,474 | 9999.99% | 0.01% |
| Feb. 1, 2025 | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 10657 | $0.00 | 10,657.0000 | 79,507,474 | 9999.99% | 0.01% |
| Feb. 1, 2025 | Quigley Jill M. | Not found | A | Stock Option (Right to Buy) | 10657 | $0.00 | 10,657.0000 | 79,507,474 | 9999.99% | 0.01% |
| Feb. 1, 2025 | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 10657 | $0.00 | 10,657.0000 | 79,507,474 | 9999.99% | 0.01% |
| Feb. 1, 2025 | FELLOWS DAVID A | Not found | A | Stock Option (Right to Buy) | 18650 | $0.00 | 18,650.0000 | 79,507,474 | 9999.99% | 0.02% |
| Nov. 30, 2024 | Jung Melita Sun | Chief Business Officer | P | Common Stock | 2250 | $5.11 | 2,250.0000 | 77,819,658 | 9999.99% | 0.00% |
| Jan. 30, 2025 | Jung Melita Sun | Chief Business Officer | A | Stock Option (Right to Buy) | 325000 | $0.00 | 325,000.0000 | 79,507,474 | 9999.99% | 0.41% |
| Jan. 30, 2025 | Kuriakose Emil | Chief Medical Officer | A | Stock Option (Right to Buy) | 485000 | $0.00 | 485,000.0000 | 79,507,474 | 9999.99% | 0.61% |
| Jan. 2, 2025 | Quigley Jill M. | Not found | S | Common Stock | 6240 | $5.72 | 8,760.0000 | 79,507,474 | 41.60% | 0.01% |
| Jan. 6, 2025 | Vignola Mark J. | Chief Financial Officer | S | Common Stock | 9059 | $5.80 | 74,752.0000 | 79,507,474 | 10.81% | 0.01% |
| Jan. 2, 2025 | Vignola Mark J. | Chief Financial Officer | S | Common Stock | 8129 | $5.72 | 83,811.0000 | 79,507,474 | 8.84% | 0.01% |
| Jan. 2, 2025 | Kuriakose Emil | Chief Medical Officer | S | Common Stock | 4481 | $5.71 | 54,269.0000 | 79,507,474 | 7.63% | 0.01% |
| Jan. 6, 2025 | Quigley Jill M. | Not found | S | Common Stock | 8760 | $5.79 | 0.0000 | 79,507,474 | 100.00% | 0.01% |
| Dec. 12, 2024 | Kuriakose Emil | Chief Medical Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 77,819,658 | 9999.99% | 0.15% |
| Dec. 5, 2024 | Burroughs Amy L. | Chief Executive Officer | P | Common Stock | 15450 | $7.15 | 19,099.0000 | 77,819,658 | 423.40% | 0.02% |
| Nov. 18, 2024 | Turner Heather D | Not found | A | Stock Option (Right to Buy) | 64000 | $0.00 | 64,000.0000 | 77,819,658 | 9999.99% | 0.08% |
| Sept. 12, 2024 | Lu Hongbo | Director | P | Common Stock | 285714 | $10.50 | 476,190.0000 | 71,259,239 | 150.00% | 0.40% |
| Sept. 12, 2024 | Lu Hongbo | Director | P | Common Stock | 190476 | $10.50 | 190,476.0000 | 71,259,239 | 9999.99% | 0.27% |
| Sept. 10, 2024 | Vignola Mark J. | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 55,000.0000 | 71,259,239 | 15.38% | 0.01% |
| Sept. 10, 2024 | Vignola Mark J. | Chief Financial Officer | M | Common Stock | 10000 | $5.36 | 101,940.0000 | 71,259,239 | 10.88% | 0.01% |
| Sept. 10, 2024 | Vignola Mark J. | Chief Financial Officer | S | Common Stock | 10000 | $11.00 | 91,940.0000 | 71,259,239 | 9.81% | 0.01% |
| Sept. 9, 2024 | Quigley Jill M. | Not found | M | Stock Option (Right to Buy) | 17235 | $0.00 | 0.0000 | 71,259,239 | 100.00% | 0.02% |
| Sept. 9, 2024 | Quigley Jill M. | Not found | M | Common Stock | 17235 | $1.82 | 32,235.0000 | 71,259,239 | 114.90% | 0.02% |
| Sept. 9, 2024 | Quigley Jill M. | Not found | S | Common Stock | 17235 | $10.00 | 15,000.0000 | 71,259,239 | 53.47% | 0.02% |
| Aug. 2, 2024 | Quigley Jill M. | Not found | S | Common Stock | 8857 | $7.50 | 15,000.0000 | 71,259,239 | 37.13% | 0.01% |
| Aug. 1, 2024 | Quigley Jill M. | Not found | S | Common Stock | 6143 | $7.68 | 23,857.0000 | 71,259,239 | 20.48% | 0.01% |
| July 16, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 623 | $10.00 | 755,635.0000 | 71,259,239 | 0.08% | 0.00% |
| July 16, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 556 | $10.00 | 1,967,924.0000 | 71,259,239 | 0.03% | 0.00% |
| July 16, 2024 | Quigley Jill M. | Not found | M | Stock Option (Right to Buy) | 400 | $0.00 | 17,235.0000 | 71,259,239 | 2.27% | 0.00% |
| July 15, 2024 | Quigley Jill M. | Not found | M | Stock Option (Right to Buy) | 14365 | $0.00 | 17,635.0000 | 71,259,239 | 44.89% | 0.02% |
| July 16, 2024 | Quigley Jill M. | Not found | S | Common Stock | 400 | $10.00 | 30,000.0000 | 71,259,239 | 1.32% | 0.00% |
| July 16, 2024 | GORDON CARL L | Director | S | Common Stock | 556 | $10.00 | 1,967,924.0000 | 71,259,239 | 0.03% | 0.00% |
| July 16, 2024 | GORDON CARL L | Director | S | Common Stock | 4009 | $10.00 | 4,839,412.0000 | 71,259,239 | 0.08% | 0.01% |
| July 15, 2024 | GORDON CARL L | Director | S | Common Stock | 6142 | $10.00 | 756,258.0000 | 71,259,239 | 0.81% | 0.01% |
| July 15, 2024 | GORDON CARL L | Director | S | Common Stock | 5401 | $10.00 | 1,968,480.0000 | 71,259,239 | 0.27% | 0.01% |
| July 15, 2024 | GORDON CARL L | Director | S | Common Stock | 39433 | $10.00 | 4,843,421.0000 | 71,259,239 | 0.81% | 0.06% |
| July 15, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 5401 | $10.00 | 1,968,480.0000 | 71,259,239 | 0.27% | 0.01% |
| July 15, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 39433 | $10.00 | 4,843,421.0000 | 71,259,239 | 0.81% | 0.06% |
| July 16, 2024 | GORDON CARL L | Director | S | Common Stock | 623 | $10.00 | 755,635.0000 | 71,259,239 | 0.08% | 0.00% |
| July 15, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 6142 | $10.00 | 756,258.0000 | 71,259,239 | 0.81% | 0.01% |
| July 16, 2024 | Quigley Jill M. | Not found | M | Common Stock | 400 | $1.82 | 30,400.0000 | 71,259,239 | 1.33% | 0.00% |
| July 16, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 4009 | $10.00 | 4,839,412.0000 | 71,259,239 | 0.08% | 0.01% |
| July 15, 2024 | Quigley Jill M. | Not found | S | Common Stock | 14365 | $10.00 | 30,000.0000 | 71,259,239 | 32.38% | 0.02% |
| July 15, 2024 | Quigley Jill M. | Not found | M | Common Stock | 14365 | $1.82 | 44,365.0000 | 71,259,239 | 47.88% | 0.02% |
| July 1, 2024 | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 4676 | $0.00 | 4,676.0000 | 71,259,239 | 9999.99% | 0.01% |
| July 1, 2024 | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 4676 | $0.00 | 4,676.0000 | 71,259,239 | 9999.99% | 0.01% |
| July 1, 2024 | Taylor Ann Elizabeth | Not found | A | Stock Option (Right to Buy) | 4676 | $0.00 | 4,676.0000 | 71,259,239 | 9999.99% | 0.01% |
| July 1, 2024 | Lu Hongbo | Not found | A | Stock Option (Right to Buy) | 4676 | $0.00 | 4,676.0000 | 71,259,239 | 9999.99% | 0.01% |
| July 1, 2024 | GORDON CARL L | Not found | A | Stock Option (Right to Buy) | 4676 | $0.00 | 4,676.0000 | 71,259,239 | 9999.99% | 0.01% |
| July 1, 2024 | FELLOWS DAVID A | Not found | A | Stock Option (Right to Buy) | 8183 | $0.00 | 8,183.0000 | 71,259,239 | 9999.99% | 0.01% |
| June 10, 2024 | Taylor Ann Elizabeth | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 71,259,239 | 9999.99% | 0.04% |
| June 10, 2024 | Lu Hongbo | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 71,259,239 | 9999.99% | 0.04% |
| June 10, 2024 | Quigley Jill M. | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 71,259,239 | 9999.99% | 0.04% |
| June 10, 2024 | GORDON CARL L | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 71,259,239 | 9999.99% | 0.04% |
| June 10, 2024 | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 71,259,239 | 9999.99% | 0.04% |
| June 10, 2024 | FELLOWS DAVID A | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 71,259,239 | 9999.99% | 0.04% |
| June 10, 2024 | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 71,259,239 | 9999.99% | 0.04% |
| May 31, 2024 | Yoon Seokho Bryan | COO and General Counsel | P | Common Stock | 4791 | $4.44 | 91,940.0000 | 71,259,239 | 5.50% | 0.01% |
| May 31, 2024 | Vignola Mark J. | Chief Financial Officer | P | Common Stock | 4791 | $4.44 | 91,940.0000 | 71,259,239 | 5.50% | 0.01% |
| May 1, 2024 | Jung Melita Sun | Chief Business Officer | A | Stock Option (Right to buy) | 475000 | $0.00 | 475,000.0000 | 71,259,239 | 9999.99% | 0.67% |
| April 1, 2024 | Vivo Opportunity, LLC | TenPercentOwner | S | Common Stock | 5451 | $6.99 | 6,244,528.0000 | 71,259,239 | 0.09% | 0.01% |
| April 2, 2024 | Vivo Opportunity, LLC | TenPercentOwner | S | Common Stock | 76346 | $6.65 | 6,341,199.0000 | 71,259,239 | 1.19% | 0.11% |
| April 2, 2024 | Vivo Opportunity, LLC | TenPercentOwner | S | Common Stock | 22084 | $6.65 | 6,267,376.0000 | 71,259,239 | 0.35% | 0.03% |
| April 2, 2024 | Vivo Opportunity, LLC | TenPercentOwner | S | Common Stock | 3050 | $6.65 | 6,241,478.0000 | 71,259,239 | 0.05% | 0.00% |
| April 3, 2024 | Vivo Opportunity, LLC | TenPercentOwner | S | Common Stock | 4149 | $6.20 | 6,237,329.0000 | 71,259,239 | 0.07% | 0.01% |
| April 1, 2024 | Vivo Opportunity, LLC | TenPercentOwner | S | Common Stock | 136255 | $6.99 | 6,417,545.0000 | 71,259,239 | 2.08% | 0.19% |
| April 1, 2024 | Vivo Opportunity, LLC | TenPercentOwner | S | Common Stock | 39411 | $6.99 | 6,289,460.0000 | 71,259,239 | 0.62% | 0.06% |
| April 3, 2024 | Vivo Opportunity, LLC | TenPercentOwner | S | Common Stock | 103870 | $6.20 | 6,237,329.0000 | 71,259,239 | 1.64% | 0.15% |
| April 3, 2024 | Vivo Opportunity, LLC | TenPercentOwner | S | Common Stock | 30047 | $6.20 | 6,237,329.0000 | 71,259,239 | 0.48% | 0.04% |
| March 1, 2024 | Burroughs Amy L. | Chief Executive Officer | A | Restricted Stock Unit | 150000 | $0.00 | 150,000.0000 | 71,259,239 | 9999.99% | 0.21% |
| March 1, 2024 | Burroughs Amy L. | Chief Executive Officer | A | Stock Option (Right to buy) | 1250000 | $0.00 | 1,250,000.0000 | 71,259,239 | 9999.99% | 1.75% |
| Jan. 23, 2024 | Yoon Seokho Bryan | COO and General Counsel | A | Stock Option (Right to Buy) | 137500 | $0.00 | 137,500.0000 | 71,259,239 | 9999.99% | 0.19% |
| Jan. 23, 2024 | Quirk Erin | President, Head of R&D | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 71,259,239 | 9999.99% | 0.21% |
| Jan. 23, 2024 | Quirk Erin | President, Head of R&D | A | Common Stock | 75000 | $0.00 | 75,000.0000 | 71,259,239 | 9999.99% | 0.11% |
| Jan. 23, 2024 | Vignola Mark J. | Chief Financial Officer | A | Stock Option (Right to Buy) | 137500 | $0.00 | 137,500.0000 | 71,259,239 | 9999.99% | 0.19% |
| Jan. 23, 2024 | Vignola Mark J. | Chief Financial Officer | A | Common Stock | 68750 | $0.00 | 87,149.0000 | 71,259,239 | 373.66% | 0.10% |
| Jan. 23, 2024 | Yoon Seokho Bryan | COO and General Counsel | A | Common Stock | 68750 | $0.00 | 87,149.0000 | 71,259,239 | 373.66% | 0.10% |
| Jan. 23, 2024 | Quigley Jill M. | Sr. Advisor & Strategy Officer | A | Common Stock | 15000 | $0.00 | 30,000.0000 | 71,259,239 | 100.00% | 0.02% |
| Nov. 30, 2023 | Yoon Seokho Bryan | COO and General Counsel | P | Common Stock | 743 | $3.78 | 18,399.0000 | 0 | 4.21% | 0.00% |
| Nov. 30, 2023 | Vignola Mark J. | Chief Financial Officer | P | Common Stock | 743 | $3.78 | 18,399.0000 | 0 | 4.21% | 0.00% |
| Nov. 15, 2023 | Quigley Jill M. | Sr. Advisor & Strategy Officer | A | Common Stock | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2023 | Quigley Jill M. | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2023 | Taylor Ann Elizabeth | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2023 | Tripuraneni Radhika | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2023 | KINDLER JEFFREY B | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2023 | Lu Hongbo | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2023 | GORDON CARL L | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2023 | FELLOWS DAVID A | Not found | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2023 | Yoon Seokho Bryan | COO and General Counsel | P | Common Stock | 9997 | $1.41 | 17,656.0000 | 0 | 130.53% | 0.00% |
| May 31, 2023 | Vignola Mark J. | Chief Financial Officer | P | Common Stock | 9997 | $1.41 | 17,656.0000 | 0 | 130.53% | 0.00% |
| May 31, 2023 | Sundaram Senthil Vel | Chief Executive Officer | P | Common Stock | 2111 | $1.41 | 9,770.0000 | 0 | 27.56% | 0.00% |
| Feb. 1, 2023 | Sundaram Senthil Vel | Chief Executive Officer | A | Stock Option (Right to Buy) | 900000 | $0.00 | 900,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 30, 2022 | Sundaram Senthil Vel | Chief Executive Officer | P | Common Stock | 3 | $1.41 | 7,659.0000 | 0 | 0.04% | 0.00% |
| Feb. 1, 2023 | Quirk Erin | President, Head of R&D | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 30, 2022 | Vignola Mark J. | Chief Financial Officer | P | Common Stock | 3 | $1.41 | 7,659.0000 | 0 | 0.04% | 0.00% |
| Feb. 1, 2023 | Vignola Mark J. | Chief Financial Officer | A | Stock Option (Right to Buy) | 360000 | $0.00 | 360,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Yoon Seokho Bryan | COO and General Counsel | A | Stock Option (Right to Buy) | 360000 | $0.00 | 360,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 30, 2022 | Yoon Seokho Bryan | COO and General Counsel | P | Common Stock | 3 | $1.41 | 7,659.0000 | 0 | 0.04% | 0.00% |